Fine comparision of the efficacy and safety between GB242 and infliximab in patients with active moderate to severe rheumatoid arthritis: a randomized, double-blind, phase III study
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI